Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
132M
-
Number of holders
-
251
-
Total 13F shares, excl. options
-
63.4M
-
Shares change
-
-312K
-
Total reported value, excl. options
-
$5.1B
-
Value change
-
-$70.7M
-
Put/Call ratio
-
0.95
-
Number of buys
-
122
-
Number of sells
-
-139
-
Price
-
$80.36
Significant Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q3 2015
323 filings reported holding ALNY - ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2015.
ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) has 251 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.4M shares
of 132M outstanding shares and own 48.24% of the company stock.
Largest 10 shareholders include FMR LLC (12.7M shares), WELLINGTON MANAGEMENT GROUP LLP (10.3M shares), VANGUARD GROUP INC (4.63M shares), Capital World Investors (1.94M shares), BlackRock Fund Advisors (1.9M shares), BlackRock Institutional Trust Company, N.A. (1.76M shares), FIRST TRUST ADVISORS LP (1.56M shares), STATE STREET CORP (1.55M shares), GILDER GAGNON HOWE & CO LLC (1.49M shares), and JENNISON ASSOCIATES LLC (1.48M shares).
This table shows the top 251 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.